These compounds may interact with:
G1/S-specific cyclin-E1
Potentially involved in: urinary bladder cancer; cancer; facial dermatosis; chronic endophthalmitis; phlyctenulosis; rosacea; bladder neoplasm; medulloblastoma; ovarian neoplasm; mammary neoplasms; liver carcinoma; adrenocortical carcinoma; breast cancer; intraductal papillary-mucinous neoplasm (ipmn); lung adenocarcinoma; lung cancer; non-small cell lung cancer; osteosarcoma; ovarian cancer; psoriasis
Disease data sourced from Pharos.